title: A pharmacotherapy review of the novel, oral antithrombotics.
abstract: Coagulation disorders account for a high incidence of death in the U.S. due to stroke, myocardial infarction, and venous thromboembolism. In the past few years, numerous agents have been brought to market for the treatment of thromboembolism or prevention of thromboembolism. Similar to warfarin, these agents can cause bleeding disorders, which may exacerbate dental care treatment plans. This literature review examines the newer agents for the treatment of thromboembolism disorders, common side effects and drug interactions, the specific medical conditions each agent treats, and the dental perspective on how to medically management patients prescribed these medications.
authors: PGY-1 Community Resident, Samford University, Birmingham, AL.
authors: Kara J
authors: KJ
authors: Walters
authors: Assistant Professor, Samford University, Birmingham, AL.
authors: Anna
authors: A
authors: Meador
authors: Assistant Professor, Samford University, Birmingham, AL (Samford) and Clinical Instructor, Augusta University College of Dental Medicine, Augusta, GA.
authors: John A
authors: JA
authors: Galdo
authors: Assistant Professor, Department of Oral Health & Diagnostic Sciences, Geriatric Dentistry, Oral Medicine/Oral Oncology, Augusta University, Augusta, GA.
authors: Katharine
authors: K
authors: Ciarrocca
mesh_terms: D000284:Administration, Oral; D000991:Antithrombins / Q000008:administration & dosage* / Q000494:pharmacology*; D017742:Dental Care for Chronically Ill; D006801:Humans; D054556:Venous Thromboembolism / Q000188:drug therapy*
chemical_list: D000991:Antithrombins
keywords: anticoagulation; medical management; pharmacy; surgery